• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    ICL Reports Fourth Quarter and Full Year 2024 Results

    2/26/25 2:05:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials
    Get the next $ICL alert in real time by email

    Delivers annual sales of $6,841 million, adjusted EBITDA of $1,469 million and earnings per share of $0.38

    Specialties-driven EBITDA reaches 70% of total adjusted EBITDA for the year and 73% in the fourth quarter

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2024. Consolidated annual sales were $6,841 million versus $7,536 million in 2023. Net income was $407 million versus $647 million, while adjusted net income was $484 million versus $715 million in 2023. Annual adjusted EBITDA was $1,469 million versus $1,754 million in 2023. Diluted earnings per share for 2024 were $0.32, while adjusted diluted EPS was $0.38. Operating cash flow was $1,468 million in 2024, similar to adjusted EBITDA, while free cash flow was $758 million. For 2024, the Company distributed $242 million in dividends to its shareholders.

    For the fourth quarter of 2024, consolidated sales were $1,601 million versus $1,690 million in the fourth quarter of 2023. Net income and adjusted net income for the fourth quarter of 2024 were $70 million and $104 million, respectively, versus $67 million and $123 million, respectively, for the fourth quarter of 2023. Adjusted EBITDA in the fourth quarter was $347 million versus $357 million in the fourth quarter of 2023. Fourth quarter diluted earnings per share were $0.06, with adjusted diluted EPS of $0.08, versus $0.05 and $0.10, respectively in the fourth quarter of 2023. Operating cash flow was $452 million in the fourth quarter of 2024, similar to the fourth quarter of 2023.

    "ICL delivered 2024 adjusted EBITDA of $1,469 million, with our specialties-driven businesses contributing 70% of that amount, as we continued to focus on cash generation while increasing market share across Industrial Products, Phosphate Solutions and Growing Solutions. We remain committed to growing our leadership position for these three businesses," said Raviv Zoller, president and CEO of ICL. "During 2024, amidst persistent potash price declines and geopolitical challenges, we achieved strong profitability and cashflow, introduced dozens of innovative specialties products, developed new global partnerships, set production records at multiple sites, completed complementary bolt-on acquisitions, and continued to be vigilant in the execution of cost savings and efficiency efforts, all while continuing to drive significant value to our shareholders through dividends. As a result of these items, as well as prudent timing of potash deliveries, we are entering 2025 in a solid position and looking forward to improving market conditions in key end-markets."

    For 2025, the Company expects the specialties-driven segments' EBITDA to be between $0.95 billion to $1.15 billion. For Potash, the Company expects 2025 sales volumes to be between 4.5 million metric tons and 4.7 million metric tons. (1a).

    Financial Figures and non-GAAP Financial Measures

     

    10-12/2024

    10-12/2023

    1-12/2024

    1-12/2023

     

    $

    millions

    % of

    Sales

    $

    millions

    % of

    Sales

    $

    millions

    % of

    Sales

    $

    millions

    % of

    Sales

    Sales

    1,601

     

    -

     

    1,690

     

    -

     

    6,841

     

    -

     

    7,536

     

    -

    Gross profit

    535

     

    33

     

    560

     

    33

     

    2,256

     

    33

     

    2,671

     

    35

    Operating income

    147

     

    9

     

    149

     

    9

     

    775

     

    11

     

    1,141

     

    15

    Adjusted operating income (1)

    190

     

    12

     

    211

     

    12

     

    873

     

    13

     

    1,218

     

    16

    Net income attributable to the Company's shareholders

    70

     

    4

     

    67

     

    4

     

    407

     

    6

     

    647

     

    9

    Adjusted net income attributable to the Company's shareholders (1)

    104

     

    6

     

    123

     

    7

     

    484

     

    7

     

    715

     

    9

    Diluted earnings per share (in dollars)

    0.06

     

    -

     

    0.05

     

    -

     

    0.32

     

    -

     

    0.50

     

    -

    Diluted adjusted earnings per share (in dollars) (2)

    0.08

     

    -

     

    0.10

     

    -

     

    0.38

     

    -

     

    0.55

     

    -

    Adjusted EBITDA (2)(3)

    347

     

    22

     

    357

     

    21

     

    1,469

     

    21

     

    1,754

     

    23

    Cash flows from operating activities (4)

    452

     

    -

     

    452

     

    -

     

    1,468

     

    -

     

    1,710

     

    -

    Purchases of property, plant and equipment and intangible assets (5)

    267

     

    -

     

    255

     

    -

     

    713

     

    -

     

    780

     

    -

    (1)

    See "Adjustments to Reported Operating and Net income (non-GAAP)" below.

    (2)

    See "Adjusted EBITDA and Diluted Adjusted Earnings Per Share for the periods of activity" below.

    (3)

    In 2024, the Company's adjusted EBITDA was positively impacted by an immaterial accounting reclassification. For further information, see below in our Potash segment results.

    (4)

    Commencing Q2 2024, management reclassified interest received as cash flows from investing activities and interest paid as cash flows from financing activities, instead of under cash provided by operating activities.

    (5)

    See "Condensed consolidated statements of cash flows (unaudited)" in the appendix below.

    Segment Information

    Industrial Products

    The Industrial Products segment produces bromine from a highly concentrated solution in the Dead Sea and bromine‑based compounds at its facilities in Israel, the Netherlands and China. In addition, the segment produces several grades of salts, magnesium chloride, magnesia-based products, phosphorus-based products and functional fluids.

    Results of operations and key indicators

     

    10-12/2024

    10-12/2023

    1-12/2024

    1-12/2023

     

    $ millions

    $ millions

    $ millions

    $ millions

    Segment Sales

    280

     

    299

     

    1,239

     

    1,227

    Sales to external customers

    275

     

    294

     

    1,220

     

    1,206

    Sales to internal customers

    5

     

    5

     

    19

     

    21

    Segment Operating Income

    55

     

    39

     

    224

     

    220

    Depreciation and amortization

    15

     

    17

     

    57

     

    57

    Segment EBITDA

    70

     

    56

     

    281

     

    277

    Capital expenditures

    38

     

    29

     

    94

     

    91

    Significant highlights for the fourth quarter

    • Flame retardants: Bromine-based sales decreased year-over-year while phosphorus-based sales increased year-over-year, with higher volumes, mainly in Europe, due to the implementation of duties on imports of tris (2-chloro-1-methylethyl) phosphate (TCPP) from China.
    • Elemental bromine: Sales were nearly flat year-over-year, as operational efficiencies allowed higher gross margins.
    • Clear brine fluids: Sales decreased year-over-year, as oil and gas demand in the Eastern Hemisphere remained softer, due to the drilling cycle operations, resulting in lower volumes sold.
    • Specialty minerals: Sales increased slightly year-over-year, due to growth in demand from the pharma and food end-markets, which was partially offset by lower demand for certain industrial applications. 

    Results analysis for the period October – December 2024

     

     

    Sales

     

    Expenses

     

    Operating

    income

     

     

    $ millions

    Q4 2023 figures

     

    299

     

     

    (260

    )

     

    39

     

    Quantity

     

    (13

    )

     

    10

     

     

    (3

    )

    Price

     

    (6

    )

     

    -

     

     

    (6

    )

    Exchange rates

     

    -

     

     

    -

     

     

    -

     

    Raw materials

     

    -

     

     

    6

     

     

    6

     

    Energy

     

    -

     

     

    2

     

     

    2

     

    Transportation

     

    -

     

     

    (4

    )

     

    (4

    )

    Operating and other expenses

     

    -

     

     

    21

     

     

    21

     

    Q4 2024 figures

     

    280

     

     

    (225

    )

     

    55

     

    • Quantity – The negative impact on operating income was primarily related to a decrease in sales volumes of bromine-based flame retardants and clear brine fluids. This was partially offset by higher sales volumes of phosphorus-based flame retardants.
    • Price – The negative impact on operating income was primarily due to lower selling prices of bromine-based industrial solutions and bromine-based flame retardants.
    • Raw materials – The positive impact on operating income was mainly due to decreased costs of Bisphenol A (BPA).
    • Operating and other expenses – The positive impact on operating income was primarily related to operational efficiencies due to higher production.

    Potash

    The Potash segment produces and sells mainly potash, salts, magnesium and electricity. Potash is produced in Israel using an evaporation process to extract potash from the Dead Sea at Sodom and in Spain using conventional mining from an underground mine. The segment also produces and sells pure magnesium, magnesium alloys and chlorine. In addition, the segment sells salt products produced at its potash site in Spain. The segment operates a power plant in Sodom, which supplies electricity and steam to ICL facilities in Israel with any surplus electricity sold to external customers.

    Results of operations and key indicators

     

     

    10-12/2024

     

    10-12/2023

     

    1-12/2024

     

    1-12/2023

     

     

    $ millions

     

    $ millions

     

    $ millions

     

    $ millions

    Segment Sales

     

    422

     

    474

     

    1,656

     

    2,182

    Potash sales to external customers

     

    315

     

    336

     

    1,237

     

    1,693

    Potash sales to internal customers

     

    30

     

    49

     

    95

     

    129

    Other and eliminations (1)

     

    77

     

    89

     

    324

     

    360

    Gross Profit

     

    162

     

    231

     

    650

     

    1,171

    Segment Operating Income

     

    69

     

    122

     

    250

     

    668

    Depreciation and amortization

     

    61

     

    46

     

    242

     

    175

    Segment EBITDA (2)

     

    130

     

    168

     

    492

     

    843

    Capital expenditures

     

    116

     

    132

     

    332

     

    384

    Potash price - CIF ($ per tonne)

     

    285

     

    345

     

    299

     

    393

    (1)

    Primarily includes salt produced in Spain, metal magnesium-based products, chlorine and sales of surplus electricity produced by ICL's power plant at the Dead Sea in Israel.

    (2)

    Following a nonmaterial accounting reclassification of certain assets, the Potash segment's EBITDA for Q4 2024 increased by $16 million and for the full year of 2024 by $65 million.

    Significant highlights for the fourth quarter

    • ICL's potash price (CIF) per tonne of $285 in the fourth quarter was 4% lower than the third quarter and 17% lower year-over-year.
    • The Grain Price Index fell by 1.1% during the fourth quarter of 2024, with soybeans, wheat and rice 6.1%, 2.7% and 1.8% lower, respectively, while corn prices increased by 6.8%.
    • The WASDE (World Agricultural Supply and Demand Estimates) report, published by the USDA in February 2025, showed a continued decrease in the expected ratio of global inventories of grains to consumption to 26.5% for the 2024/25 agriculture year, compared to 28.2% for the 2023/24 agriculture year and 28.6% for the 2022/23 agriculture year.
    • In December 2024, as part of ICL's 2025-2027 Chinese framework agreements, ICL signed contracts with its Chinese customers to supply 2,500,000 metric tonnes of potash with mutual options for an additional 960,000 metric tonnes in aggregate, over the course of the three-year term. Prices for the quantities to be supplied according to the framework agreements will be established in line with prevailing market prices in China as of the relevant date of supply.
    • Metal Magnesium: Sales decreased year-over-year, as lower prices offset higher volumes. 

    Additional segment information

    Global potash market - average prices and imports:

    Average prices

     

     

     

    10-12/2024

     

    10-12/2023

     

    VS Q4 2023

     

    7-9/2024

     

    VS Q3 2024

    Granular potash – Brazil

     

    CFR spot

    ($ per tonne)

     

    288

     

    336

     

    (14.3

    )%

     

    300

     

    (4.0

    )%

    Granular potash – Northwest Europe

     

    CIF spot/contract

    (€ per tonne)

     

    338

     

    388

     

    (12.9

    )%

     

    340

     

    (0.6

    )%

    Standard potash – Southeast Asia

     

    CFR spot

    ($ per tonne)

     

    292

     

    318

     

    (8.2

    )%

     

    283

     

    3.2

    %

    Potash imports

     

     

     

     

     

     

     

     

     

     

     

     

    To Brazil

     

    million tonnes

     

    2.9

     

    3.4

     

    (14.7

    )%

     

    3.9

     

    (25.6

    )%

    To China

     

    million tonnes

     

    3.4

     

    3.6

     

    (5.6

    )%

     

    2.8

     

    21.4

    %

    To India

     

    million tonnes

     

    1.2

     

    0.8

     

    50.0

    %

     

    0.6

     

    100.0

    %

     

    Sources: CRU (Fertilizer Week Historical Price: December 2024), SIACESP (Brazil), United Port Services (Brazil), FAI (India), Chinese customs data, Global Trade Tracker (GTT).

    Potash – Production and Sales

    Thousands of tonnes

     

    10-12/2024

     

    10-12/2023

     

    1-12/2024

     

    1-12/2023

    Production

     

    1,178

     

    1,139

     

    4,502

     

    4,420

    Total sales (including internal sales)

     

    1,259

     

    1,179

     

    4,556

     

    4,683

    Closing inventory

     

    229

     

    284

     

    229

     

    284

    Fourth quarter 2024

    • Production – Production was 39 thousand tonnes higher year-over-year, mainly due to higher production in Spain.
    • Sales – The quantity of potash sold was 80 thousand tonnes higher year-over-year, mainly due to higher sales volumes in India and Europe, partially offset by lower sales volumes in Brazil, the US and China.

    Full year 2024

    • Production – Production was 82 thousand tonnes higher year-over-year, mainly due to operational improvements in Spain, which outweighed operational challenges and war-related issues at the Dead Sea.
    • Sales – The quantity of potash sold was 127 thousand tonnes lower year-over-year, mainly due to decreased sales volumes in China and Brazil, partially offset by higher sales volumes in Europe, India and the US.

    Results analysis for the period October – December 2024

     

     

    Sales

     

    Expenses

     

    Operating

    income

     

     

    $ millions

    Q4 2023 figures

     

    474

     

     

    (352

    )

     

    122

     

    Quantity

     

    38

     

     

    (19

    )

     

    19

     

    Price

     

    (90

    )

     

    -

     

     

    (90

    )

    Exchange rates

     

    -

     

     

    1

     

     

    1

     

    Raw materials

     

    -

     

     

    (1

    )

     

    (1

    )

    Energy

     

    -

     

     

    (3

    )

     

    (3

    )

    Transportation

     

    -

     

     

    10

     

     

    10

     

    Operating and other expenses

     

    -

     

     

    11

     

     

    11

     

    Q4 2024 figures

     

    422

     

     

    (353

    )

     

    69

     

    • Quantity – The positive impact on operating income was primarily related to an increase in sales volumes of magnesium, as well as an increase in potash sales volumes in India and Europe, partially offset by lower potash sales volumes in Brazil, the US and China.
    • Price – The negative impact on operating income resulted primarily from a decrease of $60 in the potash price (CIF) per tonne, year-over-year.
    • Transportation – The positive impact on operating income was due to a decrease in inland costs and marine costs, primarily to Brazil and the US.
    • Operating and other expenses – The positive impact on operating income was primarily related to lower operational and maintenance costs.

    Phosphate Solutions

    The Phosphate Solutions segment operates ICL's phosphate value chain and uses phosphate rock and fertilizer-grade phosphoric acid to produce phosphate-based specialty products with higher added value, as well as to produce and sell phosphate-based fertilizers.

    Results of operations and key indicators (1)

     

     

    10-12/2024 (2)

     

    10-12/2023

     

    1-12/2024

     

    1-12/2023

     

     

    $ millions

     

    $ millions

     

    $ millions

     

    $ millions

    Segment Sales

     

    507

     

    515

     

    2,215

     

    2,350

    Sales to external customers

     

    475

     

    474

     

    2,049

     

    2,141

    Sales to internal customers

     

    32

     

    41

     

    166

     

    209

    Segment Operating Income

     

    81

     

    85

     

    358

     

    350

    Depreciation and amortization

     

    51

     

    54

     

    191

     

    207

    Segment EBITDA

     

    132

     

    139

     

    549

     

    557

    Capital expenditures

     

    147

     

    89

     

    340

     

    270

    (1)

    In alignment with the Company's efficiency plan, which included a change of reporting responsibilities, as of January 2024, the results of a non-phosphate related business were allocated from the Phosphate Solutions segment to Other Activities. Comparative figures have been restated to reflect the organizational change in the reportable segments.

    (2)

    For Q4 2024, Phosphate Specialties accounted for $309 million of segment sales, $44 million of operating income, $13 million of D&A and $57 million of EBITDA, while Phosphate Commodities accounted for $198 million of segment sales, $37 million of operating income, $38 million of D&A and represented $75 million of EBITDA.

    Significant highlights for the fourth quarter

    • White phosphoric acid: Sales decreased year-over-year, as higher volumes mainly in South America were unable to offset lower prices in all regions.



    • Industrial phosphates: Sales decreased year-over-year, as higher volumes in all major regions did not offset lower prices related to decreasing cost input prices.



    • Food phosphates: Sales were nearly flat year-over-year, as higher volumes were offset by lower market prices, mainly in North America, due to reduced raw material costs.



    • Battery materials: Sales in Asia increased year-over-year, as market demand expanded. Elsewhere, the Battery Materials Innovation and Qualification Center (BM-IQ) in St. Louis is nearing completion, which will allow ICL to begin qualifying battery material products for customers.



      In January 2025, the Company signed a strategic agreement with Shenzhen Dynanonic Co., Ltd. to establish LFP production in Europe. The new facility is planned to be located at ICL's Sallent site in Spain and could substantially expand the Company's battery materials business.



    • Commodity phosphates: Overall phosphate prices remained stable in the fourth quarter of 2024, as key markets – including India – continued to experience a shortage of DAP and export availability from China remained limited. Key benchmarks were on average 3% higher quarter-over-quarter.



    • Developments in key markets are described below:



      • Chinese DAP export prices ended 2024 at $615/mt, $30 above 2023 prices, as the country's trade policy continued to be a key determinant of global pricing levels. Offshore shipments were paused late in the fourth quarter and, at the time of writing, Chinese DAP/MAP exports for 2024 were estimated at 6 to 7 million mt – the second lowest amount over the past five years.



      • India's DAP price was estimated at $634/mt CFR at the end of 2024 – only $6 lower than at the beginning of the fourth quarter, defying traditionally lower demand in the Northern Hemisphere. India imported fewer than 5 million mt of DAP and ended the year with fewer than 1 million mt of stock versus average annual imports of 6 million mt and an average end-of-year stock above 2 million mt between 2019 and 2023.



      • Phosphate demand in the US was firm throughout 2024. Provisional data places fourth quarter arrivals at around 500 thousand mt, consistent with the five-year average. Imports have been supported by attractive farmer margins during recent years and the subsequent maximization of planted acreage. Additionally, local phosphate production has faced various operational challenges. Recent hurricanes not only interrupted production but also resulted in stock loss. DAP FOB NOLA ended the fourth quarter at $637/mt, $25/mt higher than the beginning of the quarter.



      • Brazilian MAP/NPS imports accelerated in the third quarter of 2024 and remained firm through the fourth quarter, due to the planting of the Safra soy crop. Weather conditions improved consistently through October and November, enabling planting to progress rapidly and supporting last minute fertilizer demand. The Brazilian MAP price ended the fourth quarter at $635/mt CFR, flat compared to the previous quarter.



    • Indian phosphoric acid prices are negotiated on a quarterly basis. The fourth quarter price was settled at $1,060/mt P2O5, $110 higher than the third quarter. For the first quarter of 2025, the price was settled at $1,055/mt, reflecting a slight decrease in DAP prices.



    • Sulphur FOB Middle East ended the fourth quarter at $165/mt, $38 higher than prevailing levels at the end of the third quarter. The increase was driven by strong demand from key end-users, including Morocco, where a new sulphur burner was ramping up, and, to a lesser extent, continued tightening of supply.

     Additional segment information

    Global phosphate commodities market - average prices:

    Average prices

     

    $ per tonne

     

    10-12/2024

     

    10-12/2023

     

    VS Q4 2023

     

    7-9/2024

     

    VS Q3 2024

    DAP

     

    CFR India Bulk Spot

     

    637

     

    594

     

    7

    %

     

    598

     

    7

    %

    TSP

     

    CFR Brazil Bulk Spot

     

    500

     

    422

     

    18

    %

     

    513

     

    (3

    )%

    SSP

     

    CPT Brazil inland 18-20% P2O5 Bulk Spot

     

    270

     

    278

     

    (3

    )%

     

    305

     

    (11

    )%

    Sulphur

     

    Bulk FOB Adnoc monthly Bulk contract

     

    139

     

    102

     

    36

    %

     

    106

     

    31

    %

     

    Source: CRU (Fertilizer Week Historical Prices, December 2024).

    Results analysis for the period October – December 2024

     

     

    Sales

     

    Expenses

     

    Operating

    income

     

     

    $ millions

    Q4 2023 figures

     

    515

     

     

    (430

    )

     

    85

     

    Quantity

     

    15

     

     

    (5

    )

     

    10

     

    Price

     

    (24

    )

     

    -

     

     

    (24

    )

    Exchange rates

     

    1

     

     

    3

     

     

    4

     

    Raw materials

     

    -

     

     

    17

     

     

    17

     

    Energy

     

    -

     

     

    1

     

     

    1

     

    Transportation

     

    -

     

     

    6

     

     

    6

     

    Operating and other expenses

     

    -

     

     

    (18

    )

     

    (18

    )

    Q4 2024 figures

     

    507

     

     

    (426

    )

     

    81

     

    • Quantity – The positive impact on operating income was due to higher sales volumes of phosphate-based food additives and MAP used as raw materials for energy storage solutions, partially offset by lower sales volumes of phosphate fertilizers and white phosphoric acid (WPA).
    • Price – The negative impact on operating income was primarily due to lower selling prices of WPA, as well as phosphate-based food additives and salts, partially offset by higher phosphate fertilizer selling prices.
    • Raw materials –The positive impact on operating income was due to the lower costs of ammonia and potassium hydroxide (KOH), partially offset by the higher cost of sulphur.
    • Transportation – The positive impact on operating income was due to a decrease in marine and inland transportation costs.
    • Operating and other expenses – The negative impact on operating income was primarily related to higher maintenance and operational expenses.

    Growing Solutions

    The Growing Solutions segment aims to achieve global leadership in plant nutrition by enhancing its position in its core markets of specialty agriculture, ornamental horticulture, turf and landscaping, fertilizers and FertilizerpluS, and by targeting high-growth markets such as Brazil, India, and China. The segment leverages its unique R&D capabilities, substantial agronomic experience, global footprint, backward integration to potash, phosphate and polysulphate and its chemistry know-how, as well as its ability to integrate and generate synergies from acquired businesses. The segment continuously works to expand its broad portfolio of specialty plant nutrition, plant stimulation and plant health solutions, which consists of enhanced efficiency and controlled release fertilizers (CRF), water-soluble fertilizers (WSF), liquid fertilizers and straights (MKP/MAP/PeKacid), FertilizerpluS, soil and foliar micronutrients, biostimulants, soil conditioners, seed treatment products and adjuvants.

    Results of operations and key indicators

     

     

    10-12/2024

     

    10-12/2023

     

    1-12/2024

     

    1-12/2023

     

     

    $ millions

     

    $ millions

     

    $ millions

     

    millions

    Segment Sales

     

    439

     

    478

     

    1,950

     

    2,073

    Sales to external customers

     

    435

     

    475

     

    1,932

     

    2,047

    Sales to internal customers

     

    4

     

    3

     

    18

     

    26

    Segment Operating Income

     

    31

     

    (5)

     

    128

     

    51

    Depreciation and amortization

     

    20

     

    20

     

    74

     

    68

    Segment EBITDA

     

    51

     

    15

     

    202

     

    119

    Capital expenditures

     

    44

     

    36

     

    98

     

    92

    Significant highlights for the fourth quarter

    Regional highlights:

    • Brazil: Sales decreased year-over-year, mainly due to exchange rate fluctuations, as lower raw material costs drove higher gross profit.



    • Europe: Sales decreased year-over-year as higher selling prices were unable to offset lower sales volumes. However, lower raw material costs drove higher gross profit.



    • North America: Sales increased year-over-year due to higher volumes and higher prices, which contributed to an increase in gross profit.



    • Asia: Sales decreased year-over-year, as higher prices were unable to offset lower volumes. However, improved product mix drove higher gross profit.

    Product highlights:

    • Specialty agriculture (SA): Sales decreased year-over-year, due to exchange rate fluctuations and lower sales volumes, mainly in Brazil, which were partially offset by higher sales volumes and selling prices in the US and India.



    • Turf and ornamental (T&O): Sales increased year-over-year, primarily due to higher sales of ornamental horticulture, driven by increased demand for CRFs in Europe.



      In December 2024, the segment completed its acquisition of GreenBest, a UK-based manufacturer of specialty fertilizers and tailored solutions. The acquisition strengthens the Company's position in the turf and landscape sector and enhances its presence in the UK market, where GreenBest's expertise in custom manufacturing capabilities complements the Company's existing portfolio.



    • FertilizerpluS: Sales decreased year-over-year, driven primarily by lower sales volumes, mainly in Europe and China, which were partially offset by higher sales volumes in the US.

    Results analysis for the period October – December 2024

     

     

    Sales

     

    Expenses

     

    Operating

    income

     

     

    $ millions

    Q4 2023 figures

     

    478

     

     

    (483

    )

     

    (5

    )

    Quantity

     

    (27

    )

     

    20

     

     

    (7

    )

    Price

     

    10

     

     

    -

     

     

    10

     

    Exchange rates

     

    (22

    )

     

    18

     

     

    (4

    )

    Raw materials

     

    -

     

     

    32

     

     

    32

     

    Operating and other expenses

     

    -

     

     

    5

     

     

    5

     

    Q4 2024 figures

     

    439

     

     

    (408

    )

     

    31

     

    • Quantity – The negative impact on operating income was primarily related to lower sales volumes of specialty agriculture and FertilizerpluS products. This impact was partially offset by higher sales volumes of turf and ornamental products.
    • Price – The positive impact on operating income was due to higher selling prices of specialty agriculture products, mainly in the US and India.
    • Exchange rates – The unfavorable impact on operating income was due to the negative impact on sales resulting from the depreciation of the average exchange rate of the Brazilian real against the US dollar, which exceeded the positive impact from lower operational costs.
    • Raw materials – The positive impact on operating income was primarily related to lower costs for commodity fertilizers and nitrogen.
    • Operating and other expenses – The positive impact on operating income was primarily related to lower maintenance and operational costs.

    Financing expenses, net

    Net financing expenses in the fourth quarter of 2024 amounted to $33 million, the same as the corresponding quarter of last year.

    Tax expenses

    In the fourth quarter of 2024, the Company's reported tax expenses amounted to $33 million, compared to $33 million in the corresponding quarter of last year, reflecting an effective tax rate of 29% and 28%, respectively.

    Liquidity and Capital Resources

    As of December 31, 2024, the Company's cash, cash equivalents, short-term investments and deposits amounted to $442 million compared to $592 million as of December 31, 2023. In addition, the Company maintained about $1.2 billion of unused credit facilities, as of December 31, 2024.

    Outstanding net debt

    As of December 31, 2024, ICL's net financial liabilities amounted to $1,851 million, a decrease of $244 million compared to December 31, 2023.

    Credit facilities

    Sustainability-linked Revolving Credit Facility (RCF)

    In April 2023, the Company entered into a Sustainability-Linked Revolving Credit Facility Agreement between its subsidiary ICL Finance B.V., as borrower, and a consortium of 12 international banks for $1,550 million.

    In April 2024, all the banks agreed to extend the RCF agreement for an additional year which is now due to expire in April 2029. As of December 31, 2024, the Company had utilized about $520 million of its $1,550 million credit facility framework.

    Securitization

    The total amount of the Company's committed securitization facility framework is $300 million, with an additional $100 million uncommitted. As of December 31, 2024, ICL had utilized approximately $176 million of the facility's framework.

    Ratings and financial covenants

    Fitch Ratings

    In June of 2024, Fitch Ratings reaffirmed the Company's long-term issuer default rating and senior unsecured rating at 'BBB-'. The outlook on the long-term issuer default rating is stable.

    S&P Ratings

    In July of 2024, S&P reaffirmed the Company's international credit rating and senior unsecured rating of 'BBB-'. In addition, S&P Maalot reaffirmed the Company's credit rating of 'ilAA' with a stable rating outlook.

    Financial covenants

    As of December 31, 2024, the Company was in compliance with all of the financial covenants stipulated in its financing agreements.

    Dividend Distribution

    In connection with ICL's fourth quarter 2024 results, the Board of Directors declared a dividend of 4.03 cents per share, or approximately $52 million. The dividend will be paid on March 25, 2025. The record date is March 12, 2025.

    About ICL

    ICL Group Ltd. is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture, and industrial markets. ICL leverages its unique bromine, potash, and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the Company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The Company employs more than 12,000 people worldwide, and its 2024 revenue totaled approximately $7 billion. For more information, visit the Company's website at www.icl-group.com1.

    We disclose in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Our management uses adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. We calculate our adjusted operating income by adjusting our operating income to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below. Certain of these items may recur. We calculate our adjusted net income attributable to the Company's shareholders by adjusting our net income attributable to the Company's shareholders to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below, excluding the total tax impact of such adjustments. We calculate our diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Our adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under "Consolidated adjusted EBITDA, and diluted adjusted Earnings Per Share for the periods of activity" below, which were adjusted for in calculating the adjusted operating income.

    You should not view adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the Company's shareholders determined in accordance with IFRS, and you should note that our definitions of adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of our non-IFRS financial measures as tools for comparison. However, we believe adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management, and investors by excluding certain items that management believes are not indicative of our ongoing operations. Our management uses these non-IFRS measures to evaluate the Company's business strategies and management performance. We believe that these non IFRS measures provide useful information to investors because they improve the comparability of our financial results between periods and provide for greater transparency of key measures used to evaluate our performance.

    (1a) The Company only provides guidance on a non-GAAP basis. The Company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the Company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material, and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. We undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The Company provides guidance for Specialties-driven EBITDA, which includes Industrial Products, Growing Solutions and Phosphate Solutions, as the Phosphate Solutions business is now predominantly specialties-focused. For our Potash business we provide sales volumes guidance. The Company believes this information provides greater transparency, as these new metrics are less impacted by fertilizer commodity prices, given the extreme volatility in recent years.

    We present a discussion in the period-to-period comparisons of the primary drivers of change in the Company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends on our businesses. We have based the following discussion on our financial statements. You should read such discussion together with our financial statements.

    _________________

    1 The reference to our website is intended to be an inactive textual reference and the information on, or accessible through, our website is not intended to be part of this Form 6-K.

    Adjustments to Reported Operating and Net income (non-GAAP)

     

     

    10-12/2024

     

    10-12/2023

     

    1-12/2024

     

    1-12/2023

     

     

    $ millions

     

    $ millions

     

    $ millions

     

    $ millions

    Operating income

     

    147

     

     

    149

     

     

    775

     

     

    1,141

     

    Charges related to the security situation in Israel (1)

     

    17

     

     

    14

     

     

    57

     

     

    14

     

    Impairment and write-off of assets and provision for site closure (2)

     

    20

     

     

    34

     

     

    35

     

     

    49

     

    Provision for early retirement (3)

     

    4

     

     

    16

     

     

    4

     

     

    16

     

    Legal proceedings (4)

     

    2

     

     

    (2

    )

     

    2

     

     

    (2

    )

    Total adjustments to operating income

     

    43

     

     

    62

     

     

    98

     

     

    77

     

    Adjusted operating income

     

    190

     

     

    211

     

     

    873

     

     

    1,218

     

    Net income attributable to the shareholders of the Company

     

    70

     

     

    67

     

     

    407

     

     

    647

     

    Total adjustments to operating income

     

    43

     

     

    62

     

     

    98

     

     

    77

     

    Total tax adjustments (5)

     

    (9

    )

     

    (6

    )

     

    (21

    )

     

    (9

    )

    Total adjusted net income - shareholders of the Company

     

    104

     

     

    123

     

     

    484

     

     

    715

     

    (1)

    For 2024 and 2023, reflects charges relating to the security situation in Israel.

    (2)

    For 2024, reflects mainly a write-off of assets resulting from the closure of small sites in Israel and Turkey, and an impairment of assets due to a regulatory decision that mandated the cessation of a certain project. For 2023, reflects mainly a write-off of assets related to restructuring at certain sites, including site closures and facility modifications, as part of the Company's global efficiency plan.

    (3)

    For 2024 and 2023, reflects provisions for early retirement, due to restructuring at certain sites, as part of the Company's global efficiency plan.

    (4)

    For 2024, reflects reimbursement of arbitration costs associated with the Ethiopian potash project. For 2023, reflects a reversal of a legal provision.

    (5)

    For 2024 and 2023, reflects the tax impact of adjustments made to operating income. 

    Consolidated adjusted EBITDA and diluted adjusted Earnings Per Share for the periods of activity

    Calculation of adjusted EBITDA was made as follows:

     

     

    10-12/2024

     

    10-12/2023

     

    1-12/2024

     

    1-12/2023

     

     

    $ millions

     

    $ millions

     

    $ millions

     

    $ millions

    Net income

     

    81

     

    84

     

     

    464

     

     

    687

     

    Financing expenses, net

     

    33

     

    33

     

     

    140

     

     

    168

     

    Taxes on income

     

    33

     

    33

     

     

    172

     

     

    287

     

    Less: Share in earnings of equity-accounted investees

     

    -

     

    (1

    )

     

    (1

    )

     

    (1

    )

    Operating income

     

    147

     

    149

     

     

    775

     

     

    1,141

     

    Depreciation and amortization

     

    157

     

    146

     

     

    596

     

     

    536

     

    Adjustments (1)

     

    43

     

    62

     

     

    98

     

     

    77

     

    Total adjusted EBITDA (2)

     

    347

     

    357

     

     

    1,469

     

     

    1,754

     

    (1)

    See "Adjustments to Reported Operating and Net income (non-GAAP)" above.

    (2)

    In 2024, the Company's adjusted EBITDA was positively impacted by an immaterial accounting reclassification. For further information, see our Potash segment results above.

    Calculation of diluted adjusted earnings per share was made as follows:

     

     

    10-12/2024

     

    10-12/2023

     

    1-12/2024

     

    1-12/2023

     

     

    $ millions

     

    $ millions

     

    $ millions

     

    $ millions

    Net income attributable to the Company's shareholders

     

    70

     

     

    67

     

     

    407

     

     

    647

     

    Adjustments (1)

     

    43

     

     

    62

     

     

    98

     

     

    77

     

    Total tax adjustments

     

    (9

    )

     

    (6

    )

     

    (21

    )

     

    (9

    )

    Adjusted net income - shareholders of the Company

     

    104

     

     

    123

     

     

    484

     

     

    715

     

    Weighted-average number of diluted ordinary shares outstanding (in thousands)

     

    1,290,330

     

     

    1,290,575

     

     

    1,290,039

     

     

    1,290,668

     

    Diluted adjusted earnings per share (in dollars) (2)

     

    0.08

     

     

    0.10

     

     

    0.38

     

     

    0.55

     

    (1)

    See "Adjustments to Reported Operating and Net income (non-GAAP)" above.

    (2)

    The diluted adjusted earnings per share is calculated by dividing the adjusted net income shareholders of the Company by the weighted-average number of diluted ordinary shares outstanding (in thousands).

    Consolidated Results Analysis

    Results analysis for the period October – December 2024

     

     

    Sales

     

    Expenses

     

    Operating

    income

     

     

    $ millions

    Q4 2023 figures

     

    1,690

     

     

    (1,541

    )

     

    149

     

    Total adjustments Q4 2023

     

    -

     

     

    62

     

     

    62

     

    Adjusted Q4 2023 figures

     

    1,690

     

     

    (1,479

    )

     

    211

     

    Quantity

     

    26

     

     

    (7

    )

     

    19

     

    Price

     

    (92

    )

     

    -

     

     

    (92

    )

    Exchange rates

     

    (23

    )

     

    22

     

     

    (1

    )

    Raw materials

     

    -

     

     

    51

     

     

    51

     

    Energy

     

    -

     

     

    (1

    )

     

    (1

    )

    Transportation

     

    -

     

     

    11

     

     

    11

     

    Operating and other expenses

     

    -

     

     

    (8

    )

     

    (8

    )

    Adjusted Q4 2024 figures

     

    1,601

     

     

    (1,411

    )

     

    190

     

    Total adjustments Q4 2024*

     

    -

     

     

    (43

    )

     

    (43

    )

    Q4 2024 figures

     

    1,601

     

     

    (1,454

    )

     

    147

     

     

    * See "Adjustments to reported Operating and Net income (non-GAAP)" above.

    • Quantity – The positive impact on operating income was primarily due to higher sales volumes of potash, magnesium, MAP used as a raw material for energy storage solutions, and phosphate-based food additives. These were partially offset by lower sales volumes of specialty agriculture products.
    • Price – The negative impact on operating income was primarily related to a decrease of $60 in the potash price (CIF) per tonne year-over-year, as well as lower selling prices of white phosphoric acid (WPA) and phosphate-based food additives. These were partially offset by higher selling prices of specialty agriculture products and phosphate fertilizers.
    • Exchange rates – The unfavorable impact on operating income was mainly due to a negative impact on sales resulting from the depreciation of the average exchange rate of the Brazilian real against the US dollar, which slightly exceeded its positive impact on operational costs.
    • Raw materials – The positive impact on operating income was due to the lower cost of commodity fertilizers and raw materials used in the production of industrial solutions products, ammonia and nitrogen. This impact was partially offset by higher costs for sulphur.
    • Transportation – The positive impact on operating income resulted from lower inland and marine transportation costs.
    • Operating and other expenses - The negative impact on operating income was primarily related to higher maintenance and operational costs, which was partially offset by operational efficiencies, mainly in the Industrial Products segment.

    Security situation in Israel

    In October 2023, the Israeli government declared a state of war in response to attacks on its civilians in the south of the country, which escalated to other areas. The security situation has presented several challenges, including disruptions in supply chains and shipping routes, personnel shortages due to recurring rounds of mobilization for reserve duty, additional costs to protect Company sites/assets, effects of reluctance to perform contractual obligations in Israel during hostilities, various bans and limitations on trade and cooperation with Israel related entities, and fluctuations in foreign currency exchange rates relative to the Israeli shekel. Additionally, regional tensions involving Houthis attacks and threats to commercial vessels have intensified, disrupting shipping routes and commercial shipping arrangements, leading to increased shipping costs.

    The Company continues to take measures to ensure the safety of its employees and business partners, as well as the communities in which it operates. It has also implemented supportive measures to accommodate employees called for reserve duty, aiming to minimize any potential impact on its business, and to avoid disruptions to production activities at its facilities in Israel.

    The security situation in the last year has not had a material impact on the Company's business results. However, as the developments related to the war, as well as its duration, are unpredictable, the Company is unable to estimate the extent of the war's potential impact on its future business and results. The Company continuously monitors developments and will take all necessary actions to minimize any negative consequences to its operations and assets.

    Forward-looking Statements

    This announcement contains statements that constitute "forward‑looking statements", many of which can be identified by the use of forward‑looking words such as "anticipate", "believe", "could", "expect", "should", "plan", "intend", "estimate", "strive", "forecast", "targets" and "potential", among others.

    Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward‑looking statements are based on our management's beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to:

    Changes in exchange rates or prices compared to those we are currently experiencing; loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and our reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; disruptions at our seaport shipping facilities or regulatory restrictions affecting our ability to export our products overseas; general market, political or economic conditions in the countries in which we operate; price increases or shortages with respect to our principal raw materials; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at our plants; labor disputes, slowdowns and strikes involving our employees; pension and health insurance liabilities; Pandemics may create disruptions, impacting our sales, operations, supply chain and customers; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in our evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of our, or our service providers', information technology systems or breaches of our, or our service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from our cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of our businesses; changes in demand for our fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond our control; sales of our magnesium products being affected by various factors that are not within our control; our ability to secure approvals and permits from the authorities in Israel to continue our phosphate mining operations in Rotem Amfert Israel; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of our workers and processes; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; including the current state of war declared in Israel and any resulting disruptions to our supply and production chains; filing of class actions and derivative actions against the Company, its executives and Board members; The Company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under "Item 3 - Key Information— D. Risk Factors" in the Company's Annual Report on Form 20-F for the year ended December 31, 2023, filed with the U.S. Securities and Exchange Commission (the "SEC") on March 14, 2023 (the "Annual Report").

    Forward looking statements speak only as at the date they are made, and we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.

    This report for the fourth quarter of 2024 (the "Quarterly Report") should be read in conjunction with the Annual Report and the report for the first, second and third quarters of 2024 published by the Company (the "prior quarterly reports"), including the description of the events occurring subsequent to the date of the statement of financial position, as filed with the U.S. SEC.

    Appendix:

    Condensed Consolidated Statements of Financial Position as of (Unaudited)

     

     

     

    December 31,

    2024

     

    December 31,

    2023

     

     

    $ millions

     

    $ millions

    Current assets

     

     

     

     

    Cash and cash equivalents

     

    327

     

    420

    Short-term investments and deposits

     

    115

     

    172

    Trade receivables

     

    1,260

     

    1,376

    Inventories

     

    1,626

     

    1,703

    Prepaid expenses and other receivables

     

    258

     

    363

    Total current assets

     

    3,586

     

    4,034

     

     

     

     

     

    Non-current assets

     

     

     

     

    Deferred tax assets

     

    143

     

    152

    Property, plant and equipment

     

    6,462

     

    6,329

    Intangible assets

     

    869

     

    873

    Other non-current assets

     

    261

     

    239

    Total non-current assets

     

    7,735

     

    7,593

     

     

     

     

     

    Total assets

     

    11,321

     

    11,627

     

     

     

     

     

    Current liabilities

     

     

     

     

    Short-term debt

     

    384

     

    858

    Trade payables

     

    1,002

     

    912

    Provisions

     

    63

     

    85

    Other payables

     

    879

     

    783

    Total current liabilities

     

    2,328

     

    2,638

     

     

     

     

     

    Non-current liabilities

     

     

     

     

    Long-term debt and debentures

     

    1,909

     

    1,829

    Deferred tax liabilities

     

    481

     

    489

    Long-term employee liabilities

     

    331

     

    354

    Long-term provisions and accruals

     

    230

     

    224

    Other

     

    55

     

    56

    Total non-current liabilities

     

    3,006

     

    2,952

     

     

     

     

     

    Total liabilities

     

    5,334

     

    5,590

     

     

     

     

     

    Equity

     

     

     

     

    Total shareholders' equity

     

    5,724

     

    5,768

    Non-controlling interests

     

    263

     

    269

    Total equity

     

    5,987

     

    6,037

     

     

     

     

     

    Total liabilities and equity

     

    11,321

     

    11,627

    Condensed Consolidated Statements of Income (Unaudited)

    (In millions except per share data)

         

     

     

    For the three-month period ended

    December 31

     

    For the year ended

    December 31

     

     

    2024

     

    2023

     

    2024

     

    2023

     

     

    $ millions

     

    $ millions

     

    $ millions

     

    $ millions

    Sales

     

    1,601

     

     

    1,690

     

     

    6,841

     

     

    7,536

     

    Cost of sales

     

    1,066

     

     

    1,130

     

     

    4,585

     

     

    4,865

     

     

     

     

     

     

     

     

     

     

    Gross profit

     

    535

     

     

    560

     

     

    2,256

     

     

    2,671

     

     

     

     

     

     

     

     

     

     

    Selling, transport and marketing expenses

     

    281

     

     

    286

     

     

    1,114

     

     

    1,093

     

    General and administrative expenses

     

    68

     

     

    71

     

     

    259

     

     

    260

     

    Research and development expenses

     

    19

     

     

    17

     

     

    69

     

     

    71

     

    Other expenses

     

    33

     

     

    44

     

     

    60

     

     

    128

     

    Other income

     

    (13

    )

     

    (7

    )

     

    (21

    )

     

    (22

    )

     

     

     

     

     

     

     

     

     

    Operating income

     

    147

     

     

    149

     

     

    775

     

     

    1,141

     

     

     

     

     

     

     

     

     

     

    Finance expenses

     

    71

     

     

    38

     

     

    181

     

     

    259

     

    Finance income

     

    (38

    )

     

    (5

    )

     

    (41

    )

     

    (91

    )

    Finance expenses, net

     

    33

     

     

    33

     

     

    140

     

     

    168

     

     

     

     

     

     

     

     

     

     

    Share in earnings of equity-accounted investees

     

    -

     

     

    1

     

     

    1

     

     

    1

     

     

     

     

     

     

     

     

     

     

    Income before taxes on income

     

    114

     

     

    117

     

     

    636

     

     

    974

     

     

     

     

     

     

     

     

     

     

    Taxes on income

     

    33

     

     

    33

     

     

    172

     

     

    287

     

     

     

     

     

     

     

     

     

     

    Net income

     

    81

     

     

    84

     

     

    464

     

     

    687

     

     

     

     

     

     

     

     

     

     

    Net income attributable to the non-controlling interests

     

    11

     

     

    17

     

     

    57

     

     

    40

     

     

     

     

     

     

     

     

     

     

    Net income attributable to the shareholders of the Company

     

    70

     

     

    67

     

     

    407

     

     

    647

     

     

     

     

     

     

     

     

     

     

    Earnings per share attributable to the shareholders of the Company:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basic earnings per share (in dollars)

     

    0.06

     

     

    0.05

     

     

    0.32

     

     

    0.50

     

     

     

     

     

     

     

     

     

     

    Diluted earnings per share (in dollars)

     

    0.06

     

     

    0.05

     

     

    0.32

     

     

    0.50

     

     

     

     

     

     

     

     

     

     

    Weighted-average number of ordinary shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basic (in thousands)

     

    1,290,260

     

     

    1,289,449

     

     

    1,289,968

     

     

    1,289,361

     

     

     

     

     

     

     

     

     

     

    Diluted (in thousands)

     

    1,290,330

     

     

    1,290,575

     

     

    1,290,039

     

     

    1,290,668

     

    The accompanying notes are an integral part of these condensed consolidated interim financial statements.

    Condensed Consolidated Statements of Cash Flows (Unaudited)

         

     

     

    For the three-month period ended

     

    For the year ended

     

     

    December 31,

    2024

     

    December 31,

    2023

     

    December 31,

    2024

     

    December 31,

    2023

     

     

    $ millions

     

    $ millions

     

    $ millions

     

    $ millions

    Cash flows from operating activities

     

     

     

     

     

     

     

     

    Net income

     

    81

     

     

    84

     

     

    464

     

     

    687

     

    Adjustments for:

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

    157

     

     

    146

     

     

    596

     

     

    536

     

    Fixed assets impairment

     

    7

     

     

    -

     

     

    14

     

     

    -

     

    Exchange rate, interest and derivative, net

     

    47

     

     

    (51

    )

     

    152

     

     

    24

     

    Tax expenses

     

    33

     

     

    33

     

     

    172

     

     

    287

     

    Change in provisions

     

    3

     

     

    9

     

     

    (50

    )

     

    (32

    )

    Other

     

    7

     

     

    22

     

     

    13

     

     

    29

     

     

     

    254

     

     

    159

     

     

    897

     

     

    844

     

     

     

     

     

     

     

     

     

     

    Change in inventories

     

    (102

    )

     

    50

     

     

    (7

    )

     

    465

     

    Change in trade receivables

     

    68

     

     

    47

     

     

    26

     

     

    252

     

    Change in trade payables

     

    87

     

     

    66

     

     

    104

     

     

    (101

    )

    Change in other receivables

     

    66

     

     

    37

     

     

    39

     

     

    26

     

    Change in other payables

     

    39

     

     

    16

     

     

    43

     

     

    (210

    )

    Net change in operating assets and liabilities

     

    158

     

     

    216

     

     

    205

     

     

    432

     

     

     

     

     

     

     

     

     

     

    Income taxes paid, net of refund

     

    (41

    )

     

    (7

    )

     

    (98

    )

     

    (253

    )

     

     

     

     

     

     

     

     

     

    Net cash provided by operating activities (*)

     

    452

     

     

    452

     

     

    1,468

     

     

    1,710

     

     

     

     

     

     

     

     

     

     

    Cash flows from investing activities

     

     

     

     

     

     

     

     

    Proceeds (payments) from deposits, net

     

    (5

    )

     

    (10

    )

     

    56

     

     

    (88

    )

    Purchases of property, plant and equipment and intangible assets

     

    (267

    )

     

    (255

    )

     

    (713

    )

     

    (780

    )

    Proceeds from divestiture of assets and businesses, net of transaction expenses

     

    -

     

     

    -

     

     

    19

     

     

    4

     

    Interest received (*)

     

    3

     

     

    3

     

     

    17

     

     

    10

     

    Business combinations

     

    (2

    )

     

    -

     

     

    (74

    )

     

    -

     

    Other

     

    1

     

     

    -

     

     

    1

     

     

    1

     

    Net cash used in investing activities

     

    (270

    )

     

    (262

    )

     

    (694

    )

     

    (853

    )

     

     

     

     

     

     

     

     

     

    Cash flows from financing activities

     

     

     

     

     

     

     

     

    Dividends paid to the Company's shareholders

     

    (68

    )

     

    (68

    )

     

    (251

    )

     

    (474

    )

    Receipts of long-term debt

     

    278

     

     

    149

     

     

    889

     

     

    633

     

    Repayments of long-term debt

     

    (383

    )

     

    (183

    )

     

    (1,302

    )

     

    (836

    )

    Receipts (Repayments) of short-term debt

     

    (8

    )

     

    64

     

     

    (1

    )

     

    (25

    )

    Interest paid (*)

     

    (43

    )

     

    (40

    )

     

    (122

    )

     

    (125

    )

    Receipts (payments) from transactions in derivatives

     

    (3

    )

     

    (1

    )

     

    (2

    )

     

    5

     

    Dividend paid to the non-controlling interests

     

    -

     

     

    -

     

     

    (57

    )

     

    (15

    )

    Net cash used in financing activities

     

    (227

    )

     

    (79

    )

     

    (846

    )

     

    (837

    )

     

     

     

     

     

     

     

     

     

    Net change in cash and cash equivalents

     

    (45

    )

     

    111

     

     

    (72

    )

     

    20

     

    Cash and cash equivalents as of the beginning of the period

     

    393

     

     

    307

     

     

    420

     

     

    417

     

    Net effect of currency translation on cash and cash equivalents

     

    (21

    )

     

    2

     

     

    (21

    )

     

    (17

    )

    Cash and cash equivalents as of the end of the period

     

    327

     

     

    420

     

     

    327

     

     

    420

     

             

    (*) Reclassification - of interest received as cash flows from investing activities and interest paid as cash flows from financing activities, instead of under cash provided by operating activities.

    Operating segment data

                   

     

     

    Industrial

    Products

     

    Potash

     

    Phosphate

    Solutions

     

    Growing

    Solutions

     

    Other

    Activities

     

    Reconciliations

     

    Consolidated

     

     

    $ millions

    For the three-month period ended December 31, 2024

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Sales to external parties

     

    275

     

    373

     

    475

     

    435

     

    43

     

     

    -

     

     

    1,601

     

    Inter-segment sales

     

    5

     

    49

     

    32

     

    4

     

    -

     

     

    (90

    )

     

    -

     

    Total sales

     

    280

     

    422

     

    507

     

    439

     

    43

     

     

    (90

    )

     

    1,601

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of sales

     

    177

     

    260

     

    344

     

    313

     

    44

     

     

    (72

    )

     

    1,066

     

    Segment operating income (loss)

     

    55

     

    69

     

    81

     

    31

     

    (8

    )

     

    (38

    )

     

    190

     

    Other expenses not allocated to the segments

     

     

     

     

     

     

     

     

     

     

     

     

     

    (43

    )

    Operating income

     

     

     

     

     

     

     

     

     

     

     

     

     

    147

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Financing expenses, net

     

     

     

     

     

     

     

     

     

     

     

     

     

    (33

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Income before income taxes

     

     

     

     

     

     

     

     

     

     

     

     

     

    114

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation, amortization and impairment

     

    15

     

    61

     

    51

     

    20

     

    4

     

     

    13

     

     

    164

     

    Capital expenditures

     

    38

     

    116

     

    147

     

    44

     

    3

     

     

    12

     

     

    360

     

    Capital expenditures as part of business combination

     

    -

     

    -

     

    -

     

    4

     

    -

     

     

    -

     

     

    4

     

                   

    Operating segment data (cont'd)

                   

     

     

    Industrial

    Products

     

    Potash

     

    Phosphate

    Solutions

     

    Growing

    Solutions

     

    Other

    Activities

     

    Reconciliations

     

    Consolidated

     

     

    $ millions

    For the three-month period ended December 31, 2023

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Sales to external parties

     

    294

     

    408

     

    474

     

    475

     

     

    39

     

     

    -

     

     

    1,690

     

    Inter-segment sales

     

    5

     

    66

     

    41

     

    3

     

     

    (1

    )

     

    (114

    )

     

    -

     

    Total sales

     

    299

     

    474

     

    515

     

    478

     

     

    38

     

     

    (114

    )

     

    1,690

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of sales

     

    217

     

    243

     

    348

     

    375

     

     

    45

     

     

    (98

    )

     

    1,130

     

    Segment operating income (loss)

     

    39

     

    122

     

    85

     

    (5

    )

     

    (12

    )

     

    (18

    )

     

    211

     

    Other expenses not allocated to the segments

     

     

     

     

     

     

     

     

     

     

     

     

     

    (62

    )

    Operating income

     

     

     

     

     

     

     

     

     

     

     

     

     

    149

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Financing expenses, net

     

     

     

     

     

     

     

     

     

     

     

     

     

    (33

    )

    Share in earnings of equity-accounted investees

     

     

     

     

     

     

     

     

     

     

     

     

     

    1

     

    Income before income taxes

     

     

     

     

     

     

     

     

     

     

     

     

     

    117

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

    17

     

    46

     

    54

     

    20

     

     

    6

     

     

    3

     

     

    146

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Capital expenditures

     

    29

     

    132

     

    89

     

    36

     

     

    6

     

     

    12

     

     

    304

     

    Information based on geographical location

    The following table presents the distribution of the operating segments sales by geographical location of the customer:

     

     

    10-12/2024

     

    10-12/2023

     

     

    $

    millions

     

    % of

    sales

     

    $

    millions

     

    % of

    sales

    USA

     

    280

     

    17

     

    295

     

    17

    Brazil

     

    276

     

    17

     

    347

     

    21

    China

     

    274

     

    17

     

    284

     

    17

    Spain

     

    73

     

    5

     

    77

     

    5

    Israel

     

    69

     

    4

     

    72

     

    4

    Germany

     

    65

     

    4

     

    68

     

    4

    India

     

    64

     

    4

     

    29

     

    2

    United Kingdom

     

    58

     

    4

     

    74

     

    4

    France

     

    48

     

    3

     

    63

     

    4

    Netherlands

     

    37

     

    2

     

    27

     

    2

    All other

     

    357

     

    23

     

    354

     

    20

    Total

     

    1,601

     

    100

     

    1,690

     

    100

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250224694694/en/

    Investor and Press Contact – Global

    Peggy Reilly Tharp

    VP, Global Investor Relations

    +1-314-983-7665

    [email protected]

    Investor and Press Contact - Israel

    Adi Bajayo

    ICL Spokesperson

    +972-3-6844459

    [email protected]

    Get the next $ICL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ICL

    DatePrice TargetRatingAnalyst
    1/21/2025$4.00 → $6.00Underweight → Equal Weight
    Barclays
    1/12/2024$6.50 → $4.00Overweight → Underweight
    Barclays
    11/14/2023$7.00 → $6.50Equal Weight → Overweight
    Barclays
    5/18/2023Buy → Neutral
    BofA Securities
    6/1/2022$12.00Equal Weight
    Barclays
    2/14/2022$9.00 → $10.00Equal-Weight
    Morgan Stanley
    12/6/2021$7.00 → $9.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ICL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ICL Group upgraded by Barclays with a new price target

      Barclays upgraded ICL Group from Underweight to Equal Weight and set a new price target of $6.00 from $4.00 previously

      1/21/25 7:50:33 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Group downgraded by Barclays with a new price target

      Barclays downgraded ICL Group from Overweight to Underweight and set a new price target of $4.00 from $6.50 previously

      1/12/24 6:56:19 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Group upgraded by Barclays with a new price target

      Barclays upgraded ICL Group from Equal Weight to Overweight and set a new price target of $6.50 from $7.00 previously

      11/14/23 7:37:49 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    SEC Filings

    See more
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/20/25 4:20:09 PM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/19/25 2:51:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/19/25 6:50:24 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by ICL Group Ltd.

      SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

      11/14/24 6:11:02 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G filed by ICL Group Ltd.

      SC 13G - ICL Group Ltd. (0000941221) (Subject)

      1/31/24 6:05:59 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G/A filed by ICL Group Ltd. (Amendment)

      SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

      1/30/24 8:10:40 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Financials

    Live finance-specific insights

    See more
    • ICL Reports First Quarter 2025 Results

      Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net in

      5/19/25 1:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces First Quarter 2025 Earnings Call

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (646) 564-2877 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employees,

      4/23/25 8:00:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • Israel Corp. Reports Results for Fourth Quarter of 2024

      TEL AVIV, Israel, March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024. Selected Financial Figures for the Fourth Quarter 2024: $m Q3/24 Q3/23 2024 2023 ILCO share in ICL profit1 30 28 175 282 Financing, G&A and other at ILCO headquarter level  2 1 - (8) Tax income (expense) of ILCO Headquarters (1) (1) 15 (1) Net profit to company's shareholders 31 28 190 273 Liquidity at the ILCO Headquarters Level2 As of December 31, 2024, total financial liabilities were $733 million, and investments in liquid assets amounted to $882 million of which $83 million are pledged deposits. Net

      3/27/25 5:48:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Leadership Updates

    Live Leadership Updates

    See more
    • ICL Announces Appointment of Elad Aharonson as New President and Chief Executive Officer

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced its Board of Directors has approved the appointment of Elad Aharonson as ICL's new president and chief executive officer, effective March 13, 2025. He will succeed Raviv Zoller who will work with Aharonson to ensure a smooth and orderly transition. Elad Aharonson has been an integral part of ICL for nearly four years, serving as president of ICL's Growing Solutions business since April of 2021. During his tenure, he led the development of ICL's specialty fertilizer solutions and the expansion of these product offerings into new territories, through both organic efforts and via acquisitions. His signif

      12/23/24 2:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces Planned Departure of President and CEO Raviv Zoller

      Zoller to continue to serve the company until a replacement has been announced ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Raviv Zoller, the company's president and CEO for the past seven years, is expected to leave the company in early 2025, following both the appointment of a replacement and a formal transition. In a letter to the company's employees, Zoller wrote, "I feel great pride, mixed with sorrow, as I announce my expected retirement from the position as president and CEO of ICL. Over the past seven years at this amazing organization, I have come to know our employees who give their heart and soul to the company. Together, we ha

      12/5/24 7:21:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Recognized by Fortune as a Company That is Changing the World

      Company's Agmatix AI-driven data platform and RegenIQ framework designated as a Friend of Farmers ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Agmatix, the company's ag tech digital start-up, has been named to Fortune's 10th Annual Change the World list. The list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Among other factors, nominees are assessed on their measurable impact on people and the planet, profitability related to their impactful work, and the degree of innovation they have demonstrated. Agmatix was recognized for its AI-driven platform, which helps

      10/15/24 4:15:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ICL Reports First Quarter 2025 Results

      Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net in

      5/19/25 1:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces First Quarter 2025 Earnings Call

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (646) 564-2877 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employees,

      4/23/25 8:00:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • Israel Corp. Reports Results for Fourth Quarter of 2024

      TEL AVIV, Israel, March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024. Selected Financial Figures for the Fourth Quarter 2024: $m Q3/24 Q3/23 2024 2023 ILCO share in ICL profit1 30 28 175 282 Financing, G&A and other at ILCO headquarter level  2 1 - (8) Tax income (expense) of ILCO Headquarters (1) (1) 15 (1) Net profit to company's shareholders 31 28 190 273 Liquidity at the ILCO Headquarters Level2 As of December 31, 2024, total financial liabilities were $733 million, and investments in liquid assets amounted to $882 million of which $83 million are pledged deposits. Net

      3/27/25 5:48:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials